Journal
MYCOSES
Volume 55, Issue -, Pages 46-57Publisher
WILEY
DOI: 10.1111/j.1439-0507.2011.02149.x
Keywords
Biofilms; fungal; C; albicans; catheter-associated infections; indwelling medical devices
Categories
Funding
- NIH [R01-DE017486-01A1]
- BRS-ACURE [Q0600136]
- NIH/NIAID [R21 AI74077-01]
- NIH/NEI [R21 EY021303]
- Astellas
- Pfizer
- Merck
Ask authors/readers for more resources
Intravascular device-related infections are often associated with biofilms (microbial communities encased within polysaccharide-rich extracellular matrix) formed by pathogens on surfaces of these devices. Candida species are the most common fungi isolated from catheter, denture and voice prosthesis-associated infections, and also are commonly isolated from contact lens-related infections (e.g. fungal keratitis). These biofilms exhibit decreased susceptibility to most antimicrobial agents, which contributes to the persistence of infection. Drug resistance in fungal biofilms is multifactorial and phase-dependent, e.g. efflux pumps mediate resistance in biofilms during early phase whereas altered membrane sterol composition contributes to resistance in mature phase. Both substrate type and surface coatings play an important role in the pathogenesis of device-related fungal biofilms. Microarray and proteomic analyses have identified the differentially expressed genes and proteins in Candida biofilms, and recent studies demonstrate that microbial biofilms interact with host immune cells. In this review, we will summarise recent advances in research on fungal biofilms and their relevance to device-associated infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available